What is he best known for?
The fields of study he is best known for:
- Enzyme
- Biochemistry
- Botany
The scientist’s investigation covers issues in Microbiology, Biochemistry, Antioxidant, Medicinal plants and Flavonoid.
His Microbiology research includes elements of Biofilm, Staphylococcus aureus and Bacteria.
His Biochemistry study often links to related topics such as Fibroblast activation protein, alpha.
His Medicinal plants research incorporates themes from Lentivirus, Virus, Virology and Antiprotozoal.
The concepts of his Flavonoid study are interwoven with issues in Biological activity, Pharmacognosy, Flavones and Stereochemistry.
His Antibacterial agent study incorporates themes from Natural product and Antimicrobial.
His most cited work include:
- Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'. (936 citations)
- Structure−Activity Relationship and Classification of Flavonoids as Inhibitors of Xanthine Oxidase and Superoxide Scavengers (772 citations)
- Proanthocyanidins in Health Care: Current and New Trends (321 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Microbiology, Traditional medicine, Biochemistry, Antimicrobial and In vitro.
Paul Cos works mostly in the field of Microbiology, limiting it down to concerns involving Biofilm and, occasionally, Potentiator.
His studies in Traditional medicine integrate themes in fields like Plasmodium falciparum, Antiprotozoal and Botany.
His study explores the link between Antiprotozoal and topics such as Leishmania infantum that cross with problems in Amastigote and Leishmania donovani.
His research integrates issues of Antibacterial agent and Trichophyton rubrum in his study of Antimicrobial.
Paul Cos studied In vitro and In vivo that intersect with Pharmacology.
He most often published in these fields:
- Microbiology (26.76%)
- Traditional medicine (19.73%)
- Biochemistry (15.38%)
What were the highlights of his more recent work (between 2018-2021)?
- Traditional medicine (19.73%)
- Antimicrobial (13.04%)
- Microbiology (26.76%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Traditional medicine, Antimicrobial, Microbiology, IC50 and Virulence.
His Traditional medicine research is multidisciplinary, relying on both Plasmodium falciparum, Glycoside and Staphylococcus aureus.
His study in Antimicrobial is interdisciplinary in nature, drawing from both Chemical fingerprinting, Cytotoxicity, Trypanosoma cruzi, Essential oil and Antiprotozoal.
The study incorporates disciplines such as Pulsed-field gel electrophoresis, Vancomycin resistant Enterococcus faecium and In vivo in addition to Microbiology.
His work in In vivo tackles topics such as In vitro which are related to areas like Phenanthridine and Extracellular.
Leishmania infantum is closely connected to Trypanosoma brucei rhodesiense in his research, which is encompassed under the umbrella topic of Antiparasitic.
Between 2018 and 2021, his most popular works were:
- Non‐Thermal Plasma as a Unique Delivery System of Short‐Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells (65 citations)
- Inhibition of Candida albicans morphogenesis by chitinase from Lactobacillus rhamnosus GG (32 citations)
- Optimization and Characterization of a Galleria mellonella Larval Infection Model for Virulence Studies and the Evaluation of Therapeutics Against Streptococcus pneumoniae. (15 citations)
In his most recent research, the most cited papers focused on:
Paul Cos mainly focuses on Microbiology, Virulence, In vivo, Computer science and Biofilm.
His works in Corpus albicans, Streptococcus pneumoniae, Pathogen, Hyphal cell wall and Pneumococcal infections are all subjects of inquiry into Microbiology.
His Corpus albicans research is multidisciplinary, incorporating perspectives in Lactobacillus rhamnosus, Lactobacillus, Chitinase and Effector.
His Virulence research is multidisciplinary, incorporating elements of Infectivity, Leishmania infantum, Leishmaniasis and Antibiotic resistance.
His studies deal with areas such as IC50, In vitro, Decoction, Apocynaceae and Plasmodium falciparum as well as In vivo.
His Biofilm research incorporates elements of Fungicide, Domiphen bromide, Potentiator, Combination therapy and Miconazole.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
